CENTENE CORPORATION for CENTENE CORPORATION
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
ACA (Patient Protection and Affordable Care Act) Marketplace Stabilization S. 1895 "Lower Health Care Costs Act" (Surprise billing, prescription drug costs, transparency, interoperability) Prescription Drug Costs Out of Network Payment (Surprise billing) HR 3630 "No Surprises Act" HR 2328 "Community Health Investment Modernization and Excellence Act of 2019" (Title IV surprise billing provisions) HR 6800 Health and Economic Recovery Omnibus Emergency Solutions Act (Marketplace, Commercial market issues) Marketplace grace period regulatory policy
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN KAELIN New | — |
| JOSEPH MUSKER | — |
Medicare/Medicaid MMM
Prescription Drug Costs ACA stabilization issues HR 2062 Overdose Prevention and Patient Safety Act (42 CFR Part2 issues) S 2012 Protecting Jessica Grubb's Legacy Act (42 CFR Part 2 issues) Medicare Advantage Medicare Part D Issues 6800 Health and Economic Recovery Omnibus Emergency Solutions Act (Marketplace, Commercial Market Issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN KAELIN New | — |
| JOSEPH MUSKER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.